Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNA

Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNA - Monitoring of genomic mutations using plasma DNA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035628

Enrollment

100

Registered

2019-01-23

Start date

2017-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small-cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Advanced non-small-cell lung cancer patients harboring EGFR mutation or ALK translocation

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Assessment of significance of the monitoring the genomic mutations using the circulating tumor DNA	—

Countries

Japan

Contacts

Public ContactYasuhiro Koh

Wakayama Medical University Internal Medicine III

ykoh@wakayama-med.ac.jp073-441-0619

Outcome results